Amyloid Beta 40 Test

Amyloid beta 40 (Aβ40) is a small protein fragment formed when a larger molecule called amyloid precursor protein (APP) is cut into pieces by enzymes. This same process produces amyloid beta 42 (Aβ42), but the 40-amino acid version is the most common form in the brain. Both Aβ40 and Aβ42 are involved in Alzheimer’s disease, yet they behave differently: Aβ42 is more prone to clump into sticky plaques inside brain tissue, while Aβ40 tends to accumulate in blood vessel walls, a condition known as cerebral amyloid angiopathy.

The structure of Aβ40 makes it versatile. In the bloodstream or brain fluid, it can exist as a loose coil, but under certain conditions it shifts into a sheet-like shape that promotes aggregation. These aggregates can form fibrils, which are thread-like deposits that interfere with normal brain and blood vessel function. Laboratory studies show that Aβ40 can even create pores, or small channels, in cell membranes, allowing calcium to flood in and disrupt cell balance. This process contributes to nerve cell injury and death.

Clinically, Aβ40 has importance well beyond the brain. Higher levels of circulating Aβ40 in the blood have been linked to worse outcomes in people with coronary heart disease, higher mortality after heart attacks, and faster decline in kidney function. This suggests Aβ40 may act as a bridge between brain health, cardiovascular disease, and kidney disease: the so-called heart-brain-renal axis. For Alzheimer’s disease, doctors often look at the ratio of Aβ42 to Aβ40 rather than either peptide alone, because this ratio reflects the balance between plaque-forming and vessel-depositing species and offers stronger diagnostic accuracy.